Autoantibody status is not associated with early treatment response to first-line methotrexate in patients with early rheumatoid arthritis

Author(s):
Dekkers, J.S.; Bergstra, S.A. (0000-0002-7136-5248); Chopra, A.; Tikly, M.; Fonseca, J.E.; Salomon-Escoto, K.; Huizinga, T.W.J. (0000-0001-7033-7520); Woude, D. van der (0000-0001-8121-5879)
Published
2019
Publication type
Article / Letter to editor
RAautoantibodiesRFACPAMTXDMARDsDASearly remission and Health Assessment Questionnaire
Date issued
2019-01-31
Language
English
Is part of
Rheumatology (2019), Vol. 58, no. 1, p. 149-153
hdl
1887/119754
doi
10.1093/rheumatology/key263